Evaluation of morroniside, iridoid glycoside from corni fructus, on diabetes-induced alterations such as oxidative stress, inflammation, and apoptosis in the liver of type 2 diabetic db/db mice

Biological and Pharmaceutical Bulletin

Volumn 34, Issue 10, 2011, Pages 1559-1565

  Park, Chan Hum ^a   Noh, Jeong Sook ^a   Kim, Ji Hyun ^a   Tanaka, Takashi ^b   Zhao, Qi ^a   Matsumoto, Kinzo ^a   Shibahara, Naotoshi ^a   Yokozawa, Takako ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Apoptosis; db db mouse; Inflammation; Liver; Morroniside; Oxidative stress

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; CYCLOOXYGENASE 2; CYTOCHROME C; GLUCOSE; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; IRIDOID; LIVER PROTECTIVE AGENT; MONOCYTE CHEMOTACTIC PROTEIN 1; MORRONISIDE; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CORNI FRUCTUS; CORNUS; CYTOKINE PRODUCTION; DOSE RESPONSE; DOWN REGULATION; DRUG DETERMINATION; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG STRUCTURE; GLUCOSE BLOOD LEVEL; HEPATITIS; LIPID PEROXIDATION; LIVER CELL DAMAGE; LIVER PARENCHYMA; LIVER PROTECTION; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PHYTOCHEMISTRY; PROTEIN EXPRESSION; TREATMENT DURATION; UPREGULATION;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; BLOOD GLUCOSE; CORNUS; CYCLOOXYGENASE 2; DIABETES MELLITUS, TYPE 2; DRUG EVALUATION, PRECLINICAL; GLYCOSIDES; HEME OXYGENASE-1; HISTONES; HYPOGLYCEMIC AGENTS; INFLAMMATION; IRIDOID GLYCOSIDES; LIVER; LIVER FUNCTION TESTS; MALE; MICE; MICE, INBRED C57BL; MOLECULAR TARGETED THERAPY; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT PREPARATIONS; REACTIVE OXYGEN SPECIES; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRANSCRIPTION FACTOR RELA;

EID: 80053548035     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.34.1559     Document Type: Article

References (48)

1. Hotamisligil G. S., Nature (London), 444, 860-867 (2006).
2. Li J. M., Shah A. M., J. Am. Soc. Nephrol., 14, S221-S226 (2003).
3. Newsholme P., Haber E. P., Hirabara S. M., Rebelato E. L. O., Procopio J., Morgan D., Oliveira-Emilio H. C., Carpinelli A. R., Curi R., J. Physiol., 583, 9-24 (2007).
4. Ceylan-Isik A. F., Fliethman R. M., Wold L. E., Ren J., Curr. Diabetes Rep., 4, 320-328 (2008).
5. Chang J. S., Chiang L. C., Hsu F. F., Lin C. C., Am. J. Chin. Med., 32, 717-725 (2004).
6. Liou S. S., Liu I. M., Hsu S. F., Cheng J. T., J. Pharm. Pharmacol., 56, 1443-1447 (2004).
7. Vareed S. K., Reddy M. K., Schutzki R. E., Nair M. G., Life Sci., 78, 777-784 (2006).
8. Yamabe N., Kang K. S., Goto E., Tanaka T., Yokozawa T., Biol. Pharm. Bull., 30, 520-526 (2007).
9. Park C. H., Cho E. J., Yokozawa T., J. Med. Food, 12, 973-981 (2009).
10. Yamabe N., Kang K. S., Matsuo Y., Tanaka T., Yokozawa T., Biol. Pharm. Bull., 30, 1289-1296 (2007).
11. Wang W., Huang W., Li L., Ai H., Sun F., Liu C., An Y., Cell. Mol. Neurobiol., 28, 293-305 (2008).
12. Yokozawa T., Yamabe N., Kim H. Y., Kang K. S., Hur J. M., Park C. H., Tanaka T., Biol. Pharm. Bull., 31, 1422-1428 (2008).
13. Park C. H., Noh J. S., Tanaka T., Yokozawa T., J. Pharm. Pharmacol., 62, 374-380 (2010).
14. Ali S. F., LeBel C. P., Bondy S. C., Neurotoxicology, 13, 637-648 (1992).
15. Mihara M., Uchiyama M., Anal. Biochem., 86, 271-278 (1978).
16. Komatsu S., Methods Mol. Biol., 355, 73-77 (2007).
17. Hatano T., Ogawa N., Kira R., Yasuhara T., Okuda T., Chem. Pharm. Bull., 37, 2083-2090 (1989).
18. Wang S. F., Chen X. G., Hu Z. D., Ju Y., Biomed. Chromatogr., 17, 306-311 (2003).
19. Park C. H., Yamabe N., Noh J. S., Kang K. S., Tanaka T., Yokozawa T., Biol. Pharm. Bull., 32, 1734-1740 (2009).
20. Wang W., Xu J., Li L., Wang P., Ji X., Ai H., Zhang L., Li L., Brain Res. Bull., 83, 196-201 (2010).
21. Xu H., Shen J., Liu H., Shi Y., Li L., Wei M., Can. J. Physiol. Pharmacol., 84, 1267-1273 (2006).
22. Forbes J. M., Coughlan M. T., Cooper M. E., Diabetes, 57, 1446-1454 (2008).
23. Bedard K., Krause K. H., Physiol. Rev., 87, 245-313 (2007).
24. Babior B. M., Lambeth J. D., Nauseef W., Arch. Biochem. Biophys., 397, 342-344 (2002).
25. Griendling K. K., Sorescu D., Ushio-Fukai M., Circ. Res., 86, 494-501 (2000).
26. Zalba G., San José G., Moreno M. U., Fortuño M. A., Fortuño A., Beaumont F. J., Díez J., Hypertension, 38, 1395-1399 (2001).
27. Etoh T., Inoguchi T., Kakimoto M., Sonoda N., Kobayashi K., Kuroda J., Sumimoto H., Nawata H., Diabetologia, 46, 1428-1437 (2003).
28. Kawahara T., Ritsick D., Cheng G., Lambeth J. D., J. Biol. Chem., 280, 31859-31869 (2005).
29. McKallip R. J., Jia W., Schlomer J., Warren J. W., Nagarkatti P. S., Nagarkatti M., Mol. Pharmacol., 70, 897-908 (2006).
30. Tong K. I., Katoh Y., Kusunoki H., Itoh K., Tanaka T., Yamamoto M., Mol. Cell. Biol., 26, 2887-2900 (2006).
31. Anwar A. A., Li F. Y. L., Leake D. S., Ishii T., Mann G. E., Siow R. C. M., Free Radic. Biol. Med., 39, 227-236 (2005).
32. He M., Siow R. C. M., Sugden D., Gao L., Cheng X., Mann G. E., Nutr. Metab. Cardiovasc. Dis., 21, 277-285 (2011).
33. Churchman A. T., Anwar A. A., Li F. Y. L., Sato H., Ishii T., Mann G. E., Siow R. C. M., J. Cell. Mol. Med., 13(8B), 2282-2292 (2009).
34. Baeuerle P. A., Henkel T., Annu. Rev. Immunol., 12, 141-179 (1994).
35. Viedt C., Hänsch G. M., Brandes R. P., Kübler W., Kreuzer J., FASEB J., 14, 2370-2372 (2000).
36. Surh Y. J., Chun K. S., Cha H. H., Han S. S., Keum Y. S., Park K. K., Lee S. S., Mutat. Res., 480-481, 243-268 (2001).
37. Guichard C. G., Moreau R., Pessayre D., Epperson T. K., Krause K. H., Biochem. Soc. Trans., 36, 920-929 (2008).
38. Paik Y. H., Schwabe R. F., Bataller R., Russo M. P., Jobin C., Brenner D. A., Hepatology, 37, 1043-1055 (2003).
39. Yoshimura T., Yuhki N., Moore S. K., Appella E., Lerman M. I., Leonard E. J., FEBS Lett., 244, 487-493 (1989).
40. Yamaguchi Y., Matsumura F., Takeya M., Ichiguchi O., Kuratsu J. I., Horiuchi T., Akizuki E., Matsuda T., Okabe K., Ohshiro H., Liang J., Mori K., Yamada S., Takahashi K., Ogawa M., Hepatology, 27, 727-734 (1998).
41. Panasiuk A., Prokopowicz D., Panasiuk B., World J. Gastroenterol., 10, 3639-3642 (2004).
42. Heymann F., Trautwein C., Tacke F., Inflamm. Allergy Drug Targets, 8, 307-318 (2009).
43. Sachse A., Wolf G., J. Am. Soc. Nephrol., 18, 2439-2446 (2007).
44. Civera M., Urios A., Garcia-Torres M. L., Ortega J., Martinez-Valls J., Cassinello N., Del Olmo J. A., Ferrandez A., Rodrigo J. M., Montoliu C., Diabetes Metab. Res. Rev., 26, 187-192 (2010).
45. Brezniceanu M. L., Liu F., Wei C. C., Chénier I., Godin N., Zhang S. L., Filep J. G., Ingelfinger J. R., Chan J. S. D., Diabetes, 57, 451-459 (2008).
46. Crompton M., Curr. Opin. Cell Biol., 12, 414-419 (2000).
47. Garcia-Ruiz C., Fernández-Checa J. C., J. Gastroenterol. Hepatol., 22 (Suppl 1), S38-S42 (2007).
48. Park C. H., Noh J. S., Yamabe N., Kang K. S., Tanaka T., Yokozawa T., Eur. J. Pharmacol., 640, 233-242 (2010).